中华流行病学杂志2024,Vol.45Issue(4) :615-620.DOI:10.3760/cma.j.cn112338-20230718-00016

高风险人群流感疫苗接种现况和免疫策略分析

Analysis of influenza vaccination status and immunization strategy in high-risk population

随海田 高汇迪 赵若颖 郭昱 苏锦锋 舒祥
中华流行病学杂志2024,Vol.45Issue(4) :615-620.DOI:10.3760/cma.j.cn112338-20230718-00016

高风险人群流感疫苗接种现况和免疫策略分析

Analysis of influenza vaccination status and immunization strategy in high-risk population

随海田 1高汇迪 1赵若颖 1郭昱 1苏锦锋 1舒祥1
扫码查看

作者信息

  • 1. 中国生物技术股份有限公司,北京 100024
  • 折叠

摘要

流感是由流感病毒引起的一种呼吸道传染性疾病,严重疾病负担常见于高风险人群.接种流感疫苗是预防流感及其并发症的有效方法,尤其是对高风险人群.虽然已有部分国家将流感疫苗纳入国家免疫规划,但全球范围内高风险人群流感疫苗接种率仍然较低.目前,流感疫苗在我国仍属于自愿自费接种的非免疫规划疫苗,且全国各地流感疫苗免疫策略差异化明显,接种率与发达国家仍有差距.进一步优化我国流感疫苗全人群免疫策略,加强流感疫苗全人群免疫策略的宣传,降低我国流感的疾病负担,是目前迫切需要解决的问题.

Abstract

Influenza is a contagious respiratory disease caused by influenza viruses,and the burden of severe disease is commonly seen in high risk populations.Influenza vaccination is an effective way to prevent influenza and its complications,especially for high risk populations.Although some countries have included influenza vaccine in their national immunization programs,influenza vaccination rates remain low globally in high risk populations.The influenza vaccine in China is still a non-immunization program vaccine that is voluntarily vaccinated at its own expense,and the influenza vaccine immunization strategy is different across the country.There is still a gap between the vaccination rate of the influenza vaccine and that of developed countries.It is an urgent problem to further optimize the whole population immunization strategy of influenza vaccine in China,strengthen the publicity of the whole population immunization strategy of influenza vaccine,and reduce the disease burden of influenza in China.

关键词

流感/临床风险人群/免疫策略

Key words

Influenza/Clinical risk groups/Immunization strategy

引用本文复制引用

出版年

2024
中华流行病学杂志
中华医学会

中华流行病学杂志

CSTPCD北大核心
影响因子:1.985
ISSN:0254-6450
参考文献量58
段落导航相关论文